Display options
Cite
Fujita Y, Taguchi H. Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chem Cent J. 2011;5(1):48doi: 10.1186/1752-153X-5-48.
Fujita, Y., & Taguchi, H. (2011). Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chemistry Central journal, 5(1), 48. https://doi.org/10.1186/1752-153X-5-48
Fujita, Yoshio, and Taguchi, Hiroaki. "Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles." Chemistry Central journal vol. 5,1 (2011): 48. doi: https://doi.org/10.1186/1752-153X-5-48
Fujita Y, Taguchi H. Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chem Cent J. 2011 Aug 23;5(1):48. doi: 10.1186/1752-153X-5-48. PMID: 21861904; PMCID: PMC3178480.
Copy Download .nbib Format: NLM
Share it on

Chem Cent J. 2011 Aug 23;5(1):48. doi: 10.1186/1752-153X-5-48.

Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.

Chemistry Central journal

Yoshio Fujita, Hiroaki Taguchi

Affiliations

  1. Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3, Minami-Tamagaki, Suzuka 513-8670, MIE, Japan. [email protected].

PMID: 21861904 PMCID: PMC3178480 DOI: 10.1186/1752-153X-5-48

Abstract

Many studies are currently investigating the development of safe and effective vaccines to prevent various infectious diseases. Multiple antigen-presenting peptide vaccine systems have been developed to avoid the adverse effects associated with conventional vaccines (i.e., live-attenuated, killed or inactivated pathogens), carrier proteins and cytotoxic adjuvants. Recently, two main approaches have been used to develop multiple antigen-presenting peptide vaccine systems: (1) the addition of functional components, e.g., T-cell epitopes, cell-penetrating peptides, and lipophilic moieties; and (2) synthetic approaches using size-defined nanomaterials, e.g., self-assembling peptides, non-peptidic dendrimers, and gold nanoparticles, as antigen-displaying platforms. This review summarizes the recent experimental studies directed to the development of multiple antigen-presenting peptide vaccine systems.

References

  1. J Control Release. 2009 Feb 20;134(1):41-6 - PubMed
  2. Immunol Cell Biol. 2003 Feb;81(1):67-72 - PubMed
  3. Arch Virol. 2011 Feb;156(2):183-202 - PubMed
  4. Biomaterials. 2009 Apr;30(12):2400-10 - PubMed
  5. Anal Biochem. 1996 Jan 1;233(1):87-93 - PubMed
  6. J Am Chem Soc. 2010 Apr 7;132(13):4678-84 - PubMed
  7. J Exp Med. 1931 Jul 31;54(3):437-47 - PubMed
  8. J Am Chem Soc. 2007 Sep 19;129(37):11653-61 - PubMed
  9. Anal Chem. 2008 Jul 15;80(14):5487-93 - PubMed
  10. J Pept Res. 2002 Sep;60(3):150-8 - PubMed
  11. Jpn J Med Sci Biol. 1991 Apr;44(2):75-80 - PubMed
  12. Trends Biotechnol. 2006 Feb;24(2):62-7 - PubMed
  13. Clin Lab Med. 2010 Mar;30(1):93-129 - PubMed
  14. Protein Sci. 2000 Dec;9(12):2294-301 - PubMed
  15. Mol Ther. 2009 Jan;17(1):95-103 - PubMed
  16. Eur J Immunol. 2004 Nov;34(11):3102-14 - PubMed
  17. Mol Immunol. 1984 Jan;21(1):13-6 - PubMed
  18. Chem Commun (Camb). 2008 May 28;(20):2367-9 - PubMed
  19. Bioorg Med Chem. 2004 Jun 15;12(12):3141-8 - PubMed
  20. J Immunol. 2002 Nov 1;169(9):4905-12 - PubMed
  21. Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5742-5 - PubMed
  22. Mol Immunol. 1994 Oct;31(15):1191-9 - PubMed
  23. Mol Pharm. 2011 Feb 7;8(1):104-16 - PubMed
  24. Biochim Biophys Acta. 2010 Jan;1805(1):25-34 - PubMed
  25. J Pept Sci. 1996 Jan-Feb;2(1):66-72 - PubMed
  26. Nat Rev Microbiol. 2009 Mar;7(3):226-36 - PubMed
  27. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3879-83 - PubMed
  28. J Infect Dis. 2000 Nov;182(5):1486-96 - PubMed
  29. J Med Chem. 2004 Jul 29;47(16):4100-4 - PubMed
  30. J Med Chem. 2010 Nov 25;53(22):8041-6 - PubMed
  31. Nanotechnology. 2010 May 14;21(19):195101 - PubMed
  32. Biochim Biophys Acta. 2010 Dec;1798(12):2286-95 - PubMed
  33. J Immunol. 1992 Mar 1;148(5):1499-505 - PubMed
  34. Bioorg Med Chem. 2003 Jan 2;11(1):159-66 - PubMed
  35. J Liposome Res. 2007;17(3-4):197-203 - PubMed
  36. AIDS. 2010 Sep 10;24(14):2211-23 - PubMed
  37. Technol Cancer Res Treat. 2004 Feb;3(1):33-40 - PubMed
  38. Expert Rev Vaccines. 2009 Jul;8(7):887-98 - PubMed
  39. J Immunol. 2000 Jan 15;164(2):900-7 - PubMed
  40. Blood Cells Mol Dis. 2007 Jan-Feb;38(1):1-7 - PubMed
  41. Nat Mater. 2008 Jul;7(7):588-95 - PubMed
  42. J Appl Toxicol. 2010 Apr;30(3):212-7 - PubMed
  43. Int Immunol. 1999 Jul;11(7):1103-10 - PubMed
  44. Vaccine. 2001 Jul 16;19(28-29):3843-52 - PubMed
  45. Vaccine. 2000 Jan 6;18(11-12):1031-9 - PubMed
  46. J Immunol. 1985 Oct;135(4):2319-22 - PubMed
  47. Nat Cell Biol. 2004 Mar;6(3):189-96 - PubMed
  48. Expert Rev Vaccines. 2010 Sep;9(9):997-1005 - PubMed
  49. AIDS. 2001 Jul 6;15(10):1239-49 - PubMed
  50. Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):622-7 - PubMed
  51. J Am Chem Soc. 2002 Feb 27;124(8):1615-9 - PubMed
  52. Nature. 1980 Jun 26;285(5767):664-7 - PubMed
  53. J Immunol. 1997 Aug 1;159(3):1383-92 - PubMed
  54. J Exp Med. 1997 Jun 2;185(11):1951-8 - PubMed
  55. Vaccine. 1994 Nov;12(14):1335-9 - PubMed
  56. Vaccine. 1994 Oct;12(13):1209-14 - PubMed
  57. Lancet. 1989 Dec 16;2(8677):1415-8 - PubMed
  58. J Pept Sci. 2000 May;6(5):235-42 - PubMed
  59. Bioorg Med Chem. 2008 Oct 1;16(19):8907-13 - PubMed
  60. Expert Rev Vaccines. 2008 Jul;7(5):597-611 - PubMed
  61. Biomaterials. 2008 May;29(13):2143-51 - PubMed
  62. Adv Exp Med Biol. 2008;609:53-63 - PubMed
  63. J Med Chem. 2008 Jan 10;51(1):167-72 - PubMed
  64. J Immunol. 2002 Mar 1;168(5):2393-401 - PubMed
  65. Nat Med. 2000 Apr;6(4):455-9 - PubMed
  66. J Med Chem. 2002 Mar 14;45(6):1387-90 - PubMed
  67. Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):134-40 - PubMed
  68. Biomaterials. 2008 Jan;29(1):111-7 - PubMed
  69. Nat Biotechnol. 2008 Jan;26(1):83-90 - PubMed
  70. Curr Opin HIV AIDS. 2010 Sep;5(5):428-34 - PubMed
  71. Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15440-5 - PubMed
  72. Bioconjug Chem. 2007 Sep-Oct;18(5):1450-9 - PubMed
  73. J Am Chem Soc. 2009 Dec 2;131(47):17042-3 - PubMed
  74. Curr Opin HIV AIDS. 2010 Sep;5(5):414-20 - PubMed
  75. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5409-13 - PubMed
  76. Vaccine. 1997 Oct;15(15):1697-705 - PubMed
  77. Analyst. 2009 Jan;134(1):170-5 - PubMed
  78. J Immunol. 1997 Aug 15;159(4):1666-8 - PubMed
  79. Science. 2010 May 14;328(5980):862-6 - PubMed
  80. Curr Opin Infect Dis. 2009 Dec;22(6):544-52 - PubMed
  81. Curr Med Chem. 2006;13(12):1371-87 - PubMed
  82. Eur J Immunol. 1997 May;27(5):1242-53 - PubMed
  83. ACS Nano. 2008 Nov 25;2(11):2263-72 - PubMed
  84. J Mol Recognit. 2003 Sep-Oct;16(5):227-33 - PubMed
  85. Curr Pharm Des. 2008;14(34):3628-36 - PubMed
  86. Drug Deliv. 2004 May-Jun;11(3):169-83 - PubMed
  87. Nanoscale Res Lett. 2009 May 8;4(8):858-864 - PubMed
  88. Int Immunol. 2006 Dec;18(12):1801-13 - PubMed
  89. Small. 2005 Mar;1(3):325-7 - PubMed
  90. Expert Rev Vaccines. 2009 Mar;8(3):333-45 - PubMed
  91. Science. 1996 Nov 1;274(5288):761-5 - PubMed
  92. Anticancer Agents Med Chem. 2009 Sep;9(7):787-97 - PubMed
  93. Chem Biol Drug Des. 2009 Jan;73(1):53-61 - PubMed
  94. Expert Opin Drug Deliv. 2010 Jun;7(6):753-63 - PubMed
  95. Biopolymers. 2002;66(3):200-16 - PubMed
  96. Vaccine. 1991 Jul;9(7):512-4 - PubMed
  97. Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):214-21 - PubMed
  98. Immunology. 2001 Apr;102(4):460-5 - PubMed
  99. J Immunol. 2009 Dec 1;183(11):7268-77 - PubMed
  100. Curr Opin Struct Biol. 2004 Aug;14(4):480-6 - PubMed
  101. Langmuir. 2010 May 18;26(10):7410-7 - PubMed
  102. J Immunol. 2008 Jun 1;180(11):7687-96 - PubMed
  103. Curr Oncol Rep. 2011 Apr;13(2):112-9 - PubMed
  104. J Med Chem. 2006 Oct 19;49(21):6364-70 - PubMed
  105. Vaccine. 2010 Mar 2;28(10):2243-2248 - PubMed
  106. Biopolymers. 2008;90(5):624-32 - PubMed
  107. J Biomed Biotechnol. 2010;2010:548280 - PubMed
  108. Peptides. 2000 Jan;21(1):9-17 - PubMed
  109. Nature. 1989 Nov 30;342(6249):561-4 - PubMed
  110. Chem Soc Rev. 2008 Sep;37(9):1896-908 - PubMed

Publication Types